We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way life science companies approach and execute pharmaceutical research. One of the more significant solutions that support the faster and more efficient development of new pharmaceutical products – such as the COVID-19 vaccine, which was developed faster than any other vaccine in history – is artificial intelligence (AI)-driven data analysis. Thanks to modern life science technology
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Connected Devices Selection: Considerations for A Digital-First Approach to Data Collection
In recent years, digital health technologies (DHTs) have significantly changed the way we collect data within clinical trials. This is partially due to the overarching industry shift toward patient-centricity, but in some cases, it is also due to the commercial availability of powerful technology solutions not previously feasible for use in medical devices. In the past, nearly all patient data have traditionally been acquired by purpose-built machines manufactured by relatively small-scale
Read More
H1 & Lokavant Partner to Power Next-Gen Clinical Trials
What You Should Know:
- H1and Lokavant today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development
- As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository.
Integrating Clinical Trial Data Sources to Intelligence Platforms
Lokavant is a clinical
Read More
Analysis: 2022 Semi-Annual Health IT Market Review
Executive Summary
Act III of COVID: Navigating the Crosscurrents of Post-Inflation
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
Cleerly Raises $192M for AI-Driven Precision Heart Health Platform
What You Should Know:
- Cleerly, the company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $192M
- This new funding, led by led by funds and accounts advised by T. Rowe Price Associates, Inc. and T. Rowe Price Investment Management, Inc., and Fidelity Management and Research Company, brings the total raised by the fast-growing health care company to $248M, which includes its Series B round in 2021
AI-enabled Approach
Read More
Medable Partners with Withings Health Solutions to Integrate Health Devices in Decentralized Clinical Trials
What You Should Know:
- Medable Inc., the leading SaaS platform provider for patient-centered clinical trials, today announced a new partnership with Withings Health Solutions, the business-to-business division of Withings, one of the global leaders in at-home connected health
- Withings’ devices will seamlessly connect to Medable’s decentralized clinical trial platform, reducing the burden on sponsors and sites while empowering patients to participate in trials from home.
Read More
ForSight Robotics Raises $55M to Develop Robotic Cataract Surgery Procedure
What You Should Know:
- Israeli-based ForSight Robotics, the pioneer in ophthalmic robotic surgery raises $55M in Series A funding to advance the world’s first surgical platform for fully robotic cataract surgery: ORYOM. The round was led by The Adani Group with existing investors Eclipse Ventures and Mithril Capital. A number of new investors, including Provenio Capital, Precision Capital, Reiya Ventures, the Ljungstrom family office, and other prominent private investors also joined the
Read More
Practicing for the Next Pandemic with Real-World Data
Data reporting challenges during the current pandemic relate to the lack of connectivity between public health and information technology (IT) reporting systems throughout the country. While access to real-world data (RWD) helps address this situation, the solution goes beyond simple accessibility.
Real-world data represents data collected outside of randomized clinical trials, such as patient data from electronic health records (EHRs), mobile and smart devices, claims and billing activity
Read More
Wysa Secures $20M for AI-Powered Mental Health Chatbot
What You Should Know:
- Wysa, a Boston, MA-based AI digital platform for mental health, today announces it has secured $20M in financing led by HealthQuad, who along with British International Investment (BII), the UK’s development finance institution, joins earlier investors W Health Ventures, Kae Capital, Google Assistant Investments, and pi Ventures amongst others.
- Funds will enable access to clinically evidenced digital therapeutics (DTx) in the US, UK, India and other global
Read More
Care Access Acquires IBPClin to Expand Decentralized Clinical Trial Capabilities to Latin America
What You Should Know:
- Today, Care Access announced the acquisition of IBPClin, a leading clinical trial center in Rio de Janeiro. As a result, Care Access will bring its innovative approach to decentralized clinical research to Latin America.
- The acquisition demonstrates progress toward building diverse representation in clinical research and is a strategic first step following Reify Health’s $220 million investment
Read More
